Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives

21 Jan 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Glioma Diagnosis and Treatment
Share to Histone Deacetylase Inhibitors Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38242327
DOI: 10.1016/j.bbamcr.2024.119673

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectivesPMID 38242327Read ↗

MGMT testing—the challenges for biomarker-based glioma treatmentSemantic proximity Read ↗

A multifaceted review of temozolomide resistance mechanisms in glioblastoma beyond O-6-methylguanine-DNA methyltransferaseSemantic proximity Read ↗

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?Semantic proximity Read ↗

From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas.Semantic proximity Read ↗

The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor Management.Semantic proximity Read ↗

Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain TumorSemantic proximity Read ↗

MGMT Status as a Clinical Biomarker in GlioblastomaSemantic proximity Read ↗

Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft modelSemantic proximity Read ↗

Regulatory mechanisms of O6-methylguanine methyltransferase expression in glioma cellsSemantic proximity Read ↗

PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideSemantic proximity Read ↗

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomasSemantic proximity Read ↗

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.